Analyst Research Report Snapshot

Title:

AmerisourceBergen Corporation

Price:

$175.00

Provider:

MarketLine (a Datamonitor Company)

Date:

06 Jul 2015

Pages:

50

Type:

AcrobatPDF

Companies referenced:

ABC.N

Available for Immediate Download
Summary:

AmerisourceBergen Corporation - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company. Features: - Detailed information on AmerisourceBergen Corporation required for business and competitor intelligence needs - A study of the major internal and external factors affecting AmerisourceBergen Corporation in the form of a SWOT analysis - An in-depth view of the business model of AmerisourceBergen Corporation including a breakdown and examination of key business segments - Intelligence on AmerisourceBergen Corporation’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about AmerisourceBergen Corporation, such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: AmerisourceBergen Corporation (ABC or 'the company') is a leading provider of pharmaceutical services in the US. It offers drug distribution and related services to healthcare providers and pharmaceutical manufacturers. The company operates in the US, Puerto Rico, Canada and select global markets. It is headquartered in Chesterbrook, Pennsylvania, and employed about 13,000 people (of which approximately 12,000 were full-time employees) as of September 30, 2013. The company recorded revenues of $87,959.2 million during the financial year ended September 2013 (FY2013), an increase of 12.7% over FY2012. The operating profit of the company was $898.4 million during FY2013, a decrease of 31.1% compared with FY2012. The net profit was $433.7 million in FY2013, a decrease of 39.7% compared with FY2012. Reasons to Purchase: - Gain understanding of AmerisourceBergen Corporation and the factors that influence its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess AmerisourceBergen Corporation as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on AmerisourceBergen Corporation’s business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.